Life ScienceCompany
Amicus Therapeutics M&A Summary
Amicus Therapeutics has acquired 2 companies.
Amicus Therapeutics’ largest acquisition to date was in 2015, when it acquired Scioderm for $229M. Amicus Therapeutics has acquired in 2 different US states. The Company’s most targeted sectors include life science (100%).
Amicus Therapeutics Business Overview
Where is Amicus Therapeutics headquartered?
Amicus Therapeutics is headquartered in Princeton, New Jersey.
What is Amicus Therapeutics’ revenue?
Amicus Therapeutics disclosed revenue of 399M USD for 2023 and 329M USD for 2022.
How many employees does Amicus Therapeutics have?
Amicus Therapeutics has 517 employees.
What sector is Amicus Therapeutics in?
Amicus Therapeutics is a life science company.
When was Amicus Therapeutics founded?
Amicus Therapeutics was founded in 2002.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity2
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Advisors 2